TriPRIL CAR T Cells in Multiple Myeloma

Recruiting

Phase 1

TriPRIL CAR T Cells in Multiple MyelomaTriPRIL CAR T Cells in Multiple Myeloma

Sponsor:

Marcela V. Maus, M.D.,Ph.D.

Code:

NCT05020444

Conditions

Multiple Myeloma

Multiple Myeloma in Relapse

Refractory Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TriPRIL CAR T Cells

Cyclophosphamide

Fludarabine

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-30. This information was provided to ClinicalTrials.gov by Marcela V. Maus, M.D.,Ph.D. on 2024-04-29.